Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Currie

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Diabetes, Obesity & Metabolism|January 14, 2014
How many people inject insulin? UK estimates from 1991 to 2010S E Holden, E A M Gale, S Jenkins-Jones, et al.
Digestion|October 16, 2009
Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitisM P Connolly, C D Poole, C J Currie, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortalityC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.
Blood|April 1, 1992
Erythropoietin therapy of myelodysplastic syndromesJ D Shepherd, C J Currie, T G Sparling, et al.
Diabetes, Obesity & Metabolism|April 12, 2014
Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational studyC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.
Diabetes, Obesity & Metabolism|November 18, 2014
Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancerS E Holden, S Jenkins-Jones, C Ll Morgan, et al.
Stroke|June 1, 1997
Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populationsC J Currie, C L Morgan, L Gill, et al.
Heart (British Cardiac Society)|March 18, 2005
Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British populationM Jones, P McEwan, C Ll Morgan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 19, 2006
Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complicationsC Ll Morgan, P McEwan, M Morrissey, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1997
NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of careC J Currie, D Kraus, C L Morgan, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|January 14, 2014
How many people inject insulin? UK estimates from 1991 to 2010S E Holden, E A M Gale, S Jenkins-Jones, et al.
Digestion|October 16, 2009
Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitisM P Connolly, C D Poole, C J Currie, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortalityC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.
Blood|April 1, 1992
Erythropoietin therapy of myelodysplastic syndromesJ D Shepherd, C J Currie, T G Sparling, et al.
Diabetes, Obesity & Metabolism|April 12, 2014
Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational studyC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.
Diabetes, Obesity & Metabolism|November 18, 2014
Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancerS E Holden, S Jenkins-Jones, C Ll Morgan, et al.
Stroke|June 1, 1997
Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populationsC J Currie, C L Morgan, L Gill, et al.
Heart (British Cardiac Society)|March 18, 2005
Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British populationM Jones, P McEwan, C Ll Morgan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 19, 2006
Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complicationsC Ll Morgan, P McEwan, M Morrissey, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1997
NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of careC J Currie, D Kraus, C L Morgan, et al.
Pageof 7